Mr. Kumar Gaurav is the Assistant General Manager of Panacea Biotec. He has a rich experience of more than 13 years in early stage Process Development and its Scale-up, Technology Transfer, Manufacturing Operations as well as Licensing and Commercialization of Vaccines and Biosimilars. He is an experienced Downstream Processing (DSP) Professional and also leads Conjugation Technology Development which includes planning, designing and execution of purification process of biologics including Conjugated Polysaccharides, Proteins and Viral Antigens. He led the development and technology exchange of a high yielding and scalable process for Pneumococcal Conjugate Vaccine. He also played a key role in the process development and successful technology transfer of Haemophilus influenzae type b conjugate vaccine resulting in to its commercial launch and as a part of Pentavalent vaccine.